American Journal of Respiratory Cell and Molecular Biology最新文献

筛选
英文 中文
Novel Small-Molecule ROCK2 Inhibitor GNS-3595 Attenuates Pulmonary Fibrosis in Preclinical Studies. 新型小分子 ROCK2 抑制剂 GNS-3595 在临床前研究中减轻肺纤维化。
IF 5.9 2区 医学
American Journal of Respiratory Cell and Molecular Biology Pub Date : 2024-10-01 DOI: 10.1165/rcmb.2023-0401OC
Soyoung Hwang, Wongil Lee, Dashnamoorthy Ravi, William Devine, Miyong Yong, R Bruce Diebold, Sang-Ae Seung, Nicholas W Ng, Jaekyoo Lee, Anu Gupta, Jong Sung Koh
{"title":"Novel Small-Molecule ROCK2 Inhibitor GNS-3595 Attenuates Pulmonary Fibrosis in Preclinical Studies.","authors":"Soyoung Hwang, Wongil Lee, Dashnamoorthy Ravi, William Devine, Miyong Yong, R Bruce Diebold, Sang-Ae Seung, Nicholas W Ng, Jaekyoo Lee, Anu Gupta, Jong Sung Koh","doi":"10.1165/rcmb.2023-0401OC","DOIUrl":"10.1165/rcmb.2023-0401OC","url":null,"abstract":"<p><p>Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease that leads to respiratory decline caused by scarring and thickening of lung tissues. Multiple pathways contribute to the fibrotic process in this disease, such as inflammation, epithelial-to-mesenchymal transition, and oxidative stress. The Rho-associated coiled-coil forming protein kinase (ROCK) signaling pathway is a key regulator of profibrotic signaling, as it affects the organization of actin-myosin and the remodeling of the extracellular matrix. ROCK1/2, a downstream effector of RhoA, is overexpressed in patients with IPF and is a promising target for IPF therapy. However, because of the hypotensive side effects of ROCK1/2 inhibitors, selective ROCK2 compounds are being explored. In this study, we report the discovery of GNS-3595, a potent and selective ROCK2 inhibitor that has ∼80-fold selectivity over ROCK1 at physiological concentrations of ATP. GNS-3595 effectively inhibited ROCK2-mediated phosphorylation of myosin light chain and reduced the expression of fibrosis-related proteins (e.g., collagen, fibronectin, and α-smooth muscle actin) in various <i>in vitro</i> cellular models. GNS-3595 also prevented transforming growth factor β-induced fibroblast-to-myofibroblast transition. In addition, in a bleomycin-induced mouse model of pulmonary fibrosis, therapeutic exposure to GNS-3595, suppressed lung fibrosis, stabilized body weight loss, and prevented fibrosis-induced lung weight gain. Transcriptome and protein expression analysis from lung tissues showed that GNS-3595 can revert the fibrosis-related gene expression induced by bleomycin. These results indicate that GNS-3595 is a highly potent, selective, and orally active ROCK2 inhibitor with promising therapeutic efficacy against pulmonary fibrosis.</p>","PeriodicalId":7655,"journal":{"name":"American Journal of Respiratory Cell and Molecular Biology","volume":" ","pages":"430-441"},"PeriodicalIF":5.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141305178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Hemodynamic, Vascular Lesion, and Cytokine/Chemokine Differences Regarding Sex in a Pulmonary Arterial Hypertension Model. PAH 模型中与性别有关的血液动力学、血管病变和细胞因子/凝血因子新差异
IF 5.9 2区 医学
American Journal of Respiratory Cell and Molecular Biology Pub Date : 2024-10-01 DOI: 10.1165/rcmb.2023-0378OC
Jenny L Hewes, Aritra Bhadra, Erin Schreck, John Thomas Goodman, Mita Patel, Chun Zhou, Ji Young Lee, Natalie R Bauer
{"title":"Novel Hemodynamic, Vascular Lesion, and Cytokine/Chemokine Differences Regarding Sex in a Pulmonary Arterial Hypertension Model.","authors":"Jenny L Hewes, Aritra Bhadra, Erin Schreck, John Thomas Goodman, Mita Patel, Chun Zhou, Ji Young Lee, Natalie R Bauer","doi":"10.1165/rcmb.2023-0378OC","DOIUrl":"10.1165/rcmb.2023-0378OC","url":null,"abstract":"<p><p>Sex differences are recognized in pulmonary hypertension. However, the progression of disease with regard to vascular lesion formation and circulating cytokines/chemokines is unknown. To determine whether vascular lesion formation, changes in hemodynamics, and alterations in circulating chemokines/cytokines differ between males and females, we used a progressive model of pulmonary arterial hypertension (PAH), Sugen/hypoxia, and analyzed cohorts of male and female rats at time points suggested to indicate worsening disease. Our analysis included echocardiography for hemodynamics, morphometry, immunofluoresecence, and chemokine/cytokine analysis of plasma at each time point in both sexes. We found that male rats had significantly increased Fulton index, compared with those for females at each time point, as well as increased medial artery thickening at 8 weeks of PAH. Furthermore, females exhibited fewer obliterative vascular lesions than males at our latest time point. Our data also show increased IL-4, granulocyte-macrophage colony-stimulating factor, IL-10, and macrophage interacting protein-1α that were not observed in females, whereas females were observed to have increased RANTES (whose name derives from Regulated upon Activation, Normal T Cell Expressed and Presumably Secreted) and CXCL-10 that were not found in males. Males also have increased infiltrating macrophages in vascular lesions, compared with females. We found that development of progressive PAH in hemodynamics, morphology, and chemokine/cytokine circulation differs significantly between males and females. These data suggest a macrophage-driven pathology in males, whereas there may be T cell protection from vascular damage in females with PAH.</p>","PeriodicalId":7655,"journal":{"name":"American Journal of Respiratory Cell and Molecular Biology","volume":" ","pages":"453-463"},"PeriodicalIF":5.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11450312/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141305177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HPS6 Deficiency Leads to Reduced Vacuolar-Type H+-ATPase and Impaired Biogenesis of Lamellar Bodies in Alveolar Type II Cells. 缺乏 HPS6 会导致肺泡 II 型细胞中 V-ATP 酶减少和薄层体生物生成受损。
IF 5.9 2区 医学
American Journal of Respiratory Cell and Molecular Biology Pub Date : 2024-10-01 DOI: 10.1165/rcmb.2022-0492OC
Zhenhua Hao, Huipeng Wang, Zixuan Zhou, Qingsong Yang, Beibei Zhang, Jing Ma, Wei Li
{"title":"HPS6 Deficiency Leads to Reduced Vacuolar-Type H<sup>+</sup>-ATPase and Impaired Biogenesis of Lamellar Bodies in Alveolar Type II Cells.","authors":"Zhenhua Hao, Huipeng Wang, Zixuan Zhou, Qingsong Yang, Beibei Zhang, Jing Ma, Wei Li","doi":"10.1165/rcmb.2022-0492OC","DOIUrl":"10.1165/rcmb.2022-0492OC","url":null,"abstract":"<p><p>Lamellar bodies (LBs) are tissue-specific lysosome-related organelles in type II alveolar cells that are the main site for the synthesis, storage, and secretion of pulmonary surfactants. Defects in pulmonary surfactants lead to a variety of respiratory and immune-related disorders. LB biogenesis is closely related to their function, but the underlying regulatory mechanism is largely unclear. Here, we found that deficiency of HPS6, a subunit of BLOC-2 (biogenesis of lysosome-related organelles complex-2), led to a reduction of the steady-state concentration of vacuolar-type H<sup>+</sup>-ATPase and an increase in the luminal pH of LBs. Furthermore, we observed increased LB size, accumulated surfactant proteins, and altered lipid profiling of lung tissue and BAL fluid due to HPS6 deficiency. These findings suggest that HPS6 regulates the distribution of vacuolar-type H<sup>+</sup>-ATPase on LBs to maintain its luminal acidity and LB homeostasis. This may provide new insights into the LB pathology.</p>","PeriodicalId":7655,"journal":{"name":"American Journal of Respiratory Cell and Molecular Biology","volume":" ","pages":"442-452"},"PeriodicalIF":5.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141305176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distinct Responses of Cystic Fibrosis Epithelial Cells to SARS-CoV-2 and Influenza A Virus. 囊性纤维化上皮细胞对 SARS-CoV-2 和甲型流感病毒的不同反应
IF 5.9 2区 医学
American Journal of Respiratory Cell and Molecular Biology Pub Date : 2024-09-23 DOI: 10.1165/rcmb.2024-0213OC
Isabel Pagani, Arianna Venturini, Valeria Capurro, Alessandro Nonis, Silvia Ghezzi, Mariateresa Lena, Beatriz Alcalá-Franco, Fabrizio Gianferro, Daniela Guidone, Carla Colombo, Nicoletta Pedemonte, Alessandra Bragonzi, Cristina Cigana, Luis J V Galietta, Elisa Vicenzi
{"title":"Distinct Responses of Cystic Fibrosis Epithelial Cells to SARS-CoV-2 and Influenza A Virus.","authors":"Isabel Pagani, Arianna Venturini, Valeria Capurro, Alessandro Nonis, Silvia Ghezzi, Mariateresa Lena, Beatriz Alcalá-Franco, Fabrizio Gianferro, Daniela Guidone, Carla Colombo, Nicoletta Pedemonte, Alessandra Bragonzi, Cristina Cigana, Luis J V Galietta, Elisa Vicenzi","doi":"10.1165/rcmb.2024-0213OC","DOIUrl":"https://doi.org/10.1165/rcmb.2024-0213OC","url":null,"abstract":"<p><p>The COVID-19 pandemic has underscored the impact of viral infections on individuals with cystic fibrosis (CF). Initial observations suggested lower COVID-19 rates among CF populations; however, subsequent clinical data have presented a more complex scenario. This study aimed to investigate how bronchial epithelial cells from CF and non-CF individuals, including various CF transmembrane conductance regulator (CFTR) mutations, respond to <i>in vitro</i> infection with SARS-CoV-2 variants and SARS-CoV. Comparisons with the Influenza A virus (IAV) were included based on evidence that CF patients experience heightened morbidity from IAV infection. Our findings showed that CF epithelial cells exhibited reduced replication of SARS-CoV-2, regardless of the type of CFTR mutation or SARS-CoV-2 variant, as well as the original 2003 SARS-Cove. In contrast, these cells displayed more efficient IAV replication compared to non-CF cells. Interestingly, the reduced susceptibility to SARS-CoV-2 in CF was not linked to the expression of angiotensin converting enzyme 2 (ACE2) receptor nor to CFTR dysfunction, as pharmacological treatments to restore CFTR function did not normalize the viral response. Both SARS-CoV-2 infection and CFTR function influenced the levels of certain cytokines and chemokines, although these effects were not correlated. Overall, this study reveals a unique viral response in CF epithelial cells, characterized by reduced replication for some viruses like SARS-CoV-2, while showing increased susceptibility to others such as IAV. This research offers a new perspective on CF and viral interactions, emphasizing the need for further investigation into the mechanisms underlying these differences. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/).</p>","PeriodicalId":7655,"journal":{"name":"American Journal of Respiratory Cell and Molecular Biology","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142279100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Piecing Together the Role of IL-4 Receptor Alpha in Allergic Asthma One Cell at a Time. 一个细胞一个细胞地拼凑 IL-4 受体 Alpha 在过敏性哮喘中的作用
IF 6.4 2区 医学
American Journal of Respiratory Cell and Molecular Biology Pub Date : 2024-09-18 DOI: 10.1165/rcmb.2024-0309ed
Miranda L Curtiss,Paul B Rothman
{"title":"Piecing Together the Role of IL-4 Receptor Alpha in Allergic Asthma One Cell at a Time.","authors":"Miranda L Curtiss,Paul B Rothman","doi":"10.1165/rcmb.2024-0309ed","DOIUrl":"https://doi.org/10.1165/rcmb.2024-0309ed","url":null,"abstract":"","PeriodicalId":7655,"journal":{"name":"American Journal of Respiratory Cell and Molecular Biology","volume":"16 1","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142264345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cav1 Scaffolding Domain Peptide (CSP7): A Novel Target for Idiopathic Pulmonary Fibrosis. Cav1 支架结构域肽 (CSP7):特发性肺纤维化的新靶点
IF 6.4 2区 医学
American Journal of Respiratory Cell and Molecular Biology Pub Date : 2024-09-18 DOI: 10.1165/rcmb.2024-0314ed
Sadiya Bi Shaikh,Irfan Rahman
{"title":"Cav1 Scaffolding Domain Peptide (CSP7): A Novel Target for Idiopathic Pulmonary Fibrosis.","authors":"Sadiya Bi Shaikh,Irfan Rahman","doi":"10.1165/rcmb.2024-0314ed","DOIUrl":"https://doi.org/10.1165/rcmb.2024-0314ed","url":null,"abstract":"","PeriodicalId":7655,"journal":{"name":"American Journal of Respiratory Cell and Molecular Biology","volume":"171 1","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142264344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging Role of CircRNA-Cacna1d in Sepsis-Induced Lung Injury: A Potential Therapeutic Target and Biomarker. CircRNA-Cacna1d 在败血症诱发的肺损伤中的新作用:潜在的治疗靶点和生物标志物
IF 6.4 2区 医学
American Journal of Respiratory Cell and Molecular Biology Pub Date : 2024-09-17 DOI: 10.1165/rcmb.2024-0424ed
Nargis Shaheen,Jing Zhao
{"title":"Emerging Role of CircRNA-Cacna1d in Sepsis-Induced Lung Injury: A Potential Therapeutic Target and Biomarker.","authors":"Nargis Shaheen,Jing Zhao","doi":"10.1165/rcmb.2024-0424ed","DOIUrl":"https://doi.org/10.1165/rcmb.2024-0424ed","url":null,"abstract":"","PeriodicalId":7655,"journal":{"name":"American Journal of Respiratory Cell and Molecular Biology","volume":"195 1","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142264348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From Data Mining to Discovery: SNHG11 as a Therapeutic Target in Pulmonary Hypertension. 从数据挖掘到发现:将 SNHG11 作为肺动脉高压的治疗靶点
IF 6.4 2区 医学
American Journal of Respiratory Cell and Molecular Biology Pub Date : 2024-09-17 DOI: 10.1165/rcmb.2024-0415ed
Yann Grobs,François Potus
{"title":"From Data Mining to Discovery: SNHG11 as a Therapeutic Target in Pulmonary Hypertension.","authors":"Yann Grobs,François Potus","doi":"10.1165/rcmb.2024-0415ed","DOIUrl":"https://doi.org/10.1165/rcmb.2024-0415ed","url":null,"abstract":"","PeriodicalId":7655,"journal":{"name":"American Journal of Respiratory Cell and Molecular Biology","volume":"7 1","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142264346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CSP7 Protects Alveolar Epithelial Cells by Targeting p53-Fibrinolytic Pathways During Lung Injuries. CSP7通过靶向肺损伤过程中的p53-纤维蛋白溶解途径保护肺泡上皮细胞
IF 6.4 2区 医学
American Journal of Respiratory Cell and Molecular Biology Pub Date : 2024-09-13 DOI: 10.1165/rcmb.2023-0453oc
Bijesh Puthusseri,Ashoka Kumar Bhagavath,Daniel Korir,Rashmi Shetty,Gretchen A Johnson,Dorota L Stankowska,Nagarjun V Konduru,Hua Tang,Sudhir Bolla,Gerald J Criner,Nathaniel Marchetti,Durgesh Nandini Das,Sreerama Shetty
{"title":"CSP7 Protects Alveolar Epithelial Cells by Targeting p53-Fibrinolytic Pathways During Lung Injuries.","authors":"Bijesh Puthusseri,Ashoka Kumar Bhagavath,Daniel Korir,Rashmi Shetty,Gretchen A Johnson,Dorota L Stankowska,Nagarjun V Konduru,Hua Tang,Sudhir Bolla,Gerald J Criner,Nathaniel Marchetti,Durgesh Nandini Das,Sreerama Shetty","doi":"10.1165/rcmb.2023-0453oc","DOIUrl":"https://doi.org/10.1165/rcmb.2023-0453oc","url":null,"abstract":"Impaired alveolar epithelial regeneration in patients with idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) is attributed to telomere dysfunction in type II alveolar epithelial cells (A2Cs). Genetic susceptibility, aging, and toxicant exposures, including tobacco smoke (TS), contribute to telomere dysfunction in A2Cs. Here we investigated whether improvement of telomere function plays a role in CSP7-mediated protection of A2Cs against ongoing senescence and apoptosis during bleomycin (BLM)-induced pulmonary fibrosis (PF) as well as alveolar injury caused by chronic TS exposure. We found a significant telomere shortening in A2Cs isolated from IPF and COPD lungs in line with other studies. These cells showed increased p53 in addition to its post-translational modification with induction of activated caspase-3 and β-galactosidase, suggesting a p53-mediated loss of A2C renewal. Further, we found increased expression of SIAH-1, a p53-inducible E3 ubiquitin ligase known to down-regulate telomere repeats binding factor 2 (TRF2). Consistent with the loss of TRF2 and upregulation of TRF1, telomerase reverse transcriptase (TERT) was downregulated in A2Cs. A2Cs from fibrotic lungs of mice either repeatedly instilled with BLM or isolated from chronic TS exposure-induced lung injury model showed reduced telomere length along with induction of p53, PAI-1, SIAH1 and TRF1 as well as loss of TRF2 and TERT, which were reversed in wild-type mice after treatment with CSP7. Interestingly, PAI-1-/- mice, or those lacking microRNA-34a expression in A2Cs, resisted telomere dysfunction, while uPA-/- mice failed to respond to CSP7 treatment, suggesting p53-microRNA-34a feed-forward induction and p53-uPA pathway contributes to telomere dysfunction.","PeriodicalId":7655,"journal":{"name":"American Journal of Respiratory Cell and Molecular Biology","volume":"92 1","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142264347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of SNHG11 as a Therapeutic Target in Pulmonary Hypertension. 确定 SNHG11 为肺动脉高压的治疗靶点
IF 6.4 2区 医学
American Journal of Respiratory Cell and Molecular Biology Pub Date : 2024-09-12 DOI: 10.1165/rcmb.2023-0428oc
Huayang Li,Quan Liu,Chiyu Liu,Shunjun Wang,Yitao Zhang,Jinyu Pan,Kaizheng Liu,Suiqing Huang,Tongxin Chu,Liqun Shang,Qingyang Song,Kangni Feng,Zhongkai Wu
{"title":"Identification of SNHG11 as a Therapeutic Target in Pulmonary Hypertension.","authors":"Huayang Li,Quan Liu,Chiyu Liu,Shunjun Wang,Yitao Zhang,Jinyu Pan,Kaizheng Liu,Suiqing Huang,Tongxin Chu,Liqun Shang,Qingyang Song,Kangni Feng,Zhongkai Wu","doi":"10.1165/rcmb.2023-0428oc","DOIUrl":"https://doi.org/10.1165/rcmb.2023-0428oc","url":null,"abstract":"Pulmonary hypertension (PH) is a life-threatening condition characterized by pulmonary vascular remodeling and endothelial dysfunction. Current therapies primarily target vasoactive imbalances but often fail to address adverse vascular remodeling. Long non-coding RNA (lncRNA), which are key regulators of various cellular processes, remain underexplored in the context of PH. To investigate the role of lncRNA in PH, we performed a comprehensive analysis using Weighted Gene Co-expression Network Analysis (WGCNA) on the GSE113439 dataset, comprising human lung tissue samples from different PH subtypes. Our analysis identified the lncRNA SNHG11 as consistently downregulated in PH. Functional assays in human pulmonary artery endothelial cells (HPAECs) demonstrated that SNHG11 plays a critical role in modulating inflammation, cell proliferation, apoptosis, and the JAK/STAT and MAPK signaling pathways. Mechanistically, SNHG11 influences the stability of PRPF8, a crucial mRNA spliceosome component, thereby affecting multiple cellular functions beyond splicing. In vivo experiments using a hypoxic rat model showed that knockdown of SNHG11 alleviates PH development and improves right ventricular function. These findings highlight SNHG11 as a key regulator in PH pathogenesis and suggest it as a potential therapeutic target.","PeriodicalId":7655,"journal":{"name":"American Journal of Respiratory Cell and Molecular Biology","volume":"6 1","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142264350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信